Article Text

PDF

Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin
  1. D Roy1,*,
  2. J Quiles1,
  3. D C Gaze2,
  4. P Collinson2,
  5. J C Kaski1,
  6. G F Baxter3
  1. 1Cardiological Sciences, St George’s Hospital Medical School, London, UK
  2. 2Chemical Pathology, St George’s Hospital Medical School
  3. 3Department of Basic Sciences, The Royal Veterinary College, London UK
  1. Correspondence to:
    Dr Gary F Baxter
    Department of Basic Sciences, The Royal Veterinary College, University of London, Royal College Street, London NW1 OUT, UK; gfbaxter{at}rvc.ac.uk

Statistics from Altmetric.com

Ischaemia modified albumin (IMA) is a recently developed biomarker of transient myocardial ischaemia.1 Circulating IMA is increased in patients with myocardial ischaemia, after percutaneous coronary intervention,2,3 or in acute coronary syndromes.4 The test has recently been licensed by the US Food and Drug Administration for diagnostic use in suspected myocardial ischaemia. IMA is serum albumin in which the N-terminus has been chemically modified. The diagnostic albumin Co2+ binding (ACB) test is based for IMA on the observation that the affinity of serum albumin for Co2+ is reduced after N-terminus modifications. It has been proposed that reactive oxygen species (ROS) such as superoxide (O2) and hydroxyl (OH) radicals generated during myocardial ischaemia–reperfusion modify the N-terminus of serum albumin resulting in IMA formation but, so far, direct evidence to support this is scarce. We hypothesised that ROS generation causes the formation of IMA. Our objective was to model the formation of IMA in vitro by using chemically generated ROS and the OH radical scavenger mercaptopropionylglycine (MPG).

MATERIALS AND METHODS

All reagents were obtained from Sigma-Aldrich (Poole, Dorset, UK) and normal human serum from the North London Transfusion Service (London, UK). Serum pH was 7.35–7.45 at 37°C and was unaltered by any of the reactants during the 15 minute experimental time course. Five millilitre serum aliquots (eight replicate experiments per group) were randomly selected for the following incubations for 15 minutes at 37°C. Group 1, peroxide treated (H2O2): serum was incubated with H2O2 100 μM. Group 2, superoxide treated (O2): serum was incubated with a xanthine-xanthine oxidase O2 generating system consisting of 100 μM xanthine plus 0.05 U/ml xanthine oxidase (xanthine → urate + O2). Group 3, hydroxyl treated (OH): OH was generated by the Fenton reaction and Cu2+ 0.1 mmol/l catalysed the generation of OH from H2O2 100 μM (H2O2 + Cu+OH + OH + Cu2+. Group 4, Cu2+ control: aliquots of serum were incubated with 0.1 mM CuSO4 as a technical control for group 3. Group 5, OH + MPG treated: aliquots of serum were incubated with the OH generating mixture (as in group 3) with the addition of MPG 1 mM. Group 6, control: serum was incubated for 15 minutes without the addition of any reactants.

Samples were withdrawn for analysis of IMA at baseline and after 2, 5, 10, and 15 minutes’ incubation. Samples were frozen at −70°C for blinded IMA determination by the ACB test (ACB Test, Ischemia Technologies Inc, Denver Colorado, USA) on a Roche Cobas MIRA PLUS analyser (ABX Ltd, London, UK). The principle of the test is as follows. Co2+ is added to serum. Co2+ not sequestered at the N-terminus of albumin is detected by dithiothreitol as a colorimetric indicator. In normal serum, more Co2+ is sequestered at the N-terminus of albumin, leaving less Co2+ to react to form a coloured product. After chemical modification of serum, Co2+ is not sequestered at the N-terminus of albumin, leaving more free Co2+ to react. The total interassay coefficient of variation was 4.9–7.5% at 72.54–140.16 U/ml for quality control material. For human serum pools, the total coefficient of variation was 5.3–8.8% at 95.07–97.35 U/ml.

The percentage change in IMA in each group was calculated as follows: (IMA concentration at each time point − baseline IMA concentrations)/baseline IMA concentration × 100. Results are expressed as mean (SE) of eight replicate experiments. IMA concentrations for each treatment were time matched by repeated measures analysis of variance with Bonferroni post hoc comparisons by SPSS 11.0 statistical software (SPSS Inc, Chicago, Illinois, USA). Results were considered significant when p < 0.05.

RESULTS

Table 1 presents changes in IMA concentration. In control serum (group 6) IMA concentrations did not change significantly at any time point. Neither H2O2 (group 1) nor O2 (group 2) caused any significant change in IMA concentration during the experimental time course compared with control. However, generation of OH by the Fenton reaction (group 3) was associated with a rapid rise of IMA concentration. A maximum increase of 43.6% greater than baseline was observed at 15 minutes. The addition of the OH scavenger MPG (group 5) to the Fenton reaction mixture attenuated the production of IMA (no significant difference versus control group 6).

Table 1

 Ischaemia modified albumin percentage change from baseline concentrations

Separate titrimetric analysis confirmed that H2O2 concentration was reduced by 22.0 (3.0)% (four determinations) during 15 minutes’ incubation as a result of serum catalase activity. Serum albumin concentration, determined by immunonephelometric assay, was 42.4 g/l before treatment and was not altered by 15 minutes’ incubation with any of the reactants studied.

Since Cu2+ may interfere with the Co2+ binding assay, an important technical control in our experiments was group 4. We observed that Cu2+ 0.1 mM in the absence of OH generation resulted in no significant change in IMA concentrations. Theoretically, Cu2+ bound to the N-terminus prevents Co2+ binding because the binding constant for Cu2+ (Ka  =  1.5 × 1016 l/mol) is many orders of magnitude higher than that for Co2+ (Ka  =  6.5 × 103 l/mol). However, in these experiments we observed no appreciable interference of Cu2+.

DISCUSSION

In vivo modifications of the albumin N-terminus are proposed to be related to the ROS production during myocardial ischaemia–reperfusion. For example, an increase in IMA was observed in patients minutes after transient occlusion and reperfusion during coronary angioplasty.2,3 The present in vitro investigation shows for the first time that IMA formation is directly related to ROS generation and provides novel information on the nature of the species contributing to IMA formation, namely OH.

Previous studies in vitro have shown that the exposure of albumin to OH generated by copper (at similar concentrations to those used in our experimental series) and ascorbate resulted in modification of albumin in a site specific manner, rather than generalised degradation.5 ROS generation in vitro caused structural changes in a synthetic N-terminus tetrapeptide, an octapeptide, and human albumin with loss of Co2+ binding capacity.6 Our data are in accordance with these findings, since we show here that OH generation caused a rise of IMA concentrations. Moreover, the role of OH was confirmed by attenuation of IMA formation in the presence of the OH scavenger MPG.

Intriguingly, neither H2O2 nor O2 alone resulted in significant IMA formation. It seems unlikely that the lack of effect of H2O2 on IMA formation was caused by inactivation by the enzyme catalase present in serum, since we observed only partial degradation of H2O2 (22%) during 15 minutes’ incubation. Thus, the H2O2 concentration remained high (> 70 μM) throughout the experimental time course. The dismutation of O2 by extracellular superoxide dismutase (SOD) present in serum undoubtedly occurs in vitro, just as it does in vivo. Moreover, the presence of intracellular SOD isoenzymes in vivo may further reduce the availability of O2. At present, we cannot say whether the efficiency of extracellular SOD in accomplishing the dismutation of O2 accounts for the lack of effect of O2 or whether O2 has low chemical reactivity with albumin in vitro. It has been suggested that O2 per se is not deleterious but serves as a source of highly reactive secondary species such as OH, which are responsible for biological damage.

These data support the hypothesis that ROS, and specifically in our hands OH, may chemically modify human serum albumin, resulting in IMA formation. This appears to be a plausible mechanism underlying this new diagnostic test. To improve the clinical utility of IMA a clear understanding of the mechanism of the reaction relevant to in vivo ischaemia–reperfusion is essential. Clearly, further in vivo studies supported by data from clinical trials are required to confirm the novel mechanism we have identified in these in vitro studies. Moreover, it will be important to elucidate the anatomical sites of IMA formation and its value in the diagnosis of disease states associated with oxidative stress, including myocardial ischaemia.

REFERENCES

View Abstract

Footnotes

  • * Also the Department of Basic Sciences, The Royal Veterinary College, London UK

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.